6-31558211-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005007.4(NFKBIL1):c.746G>A(p.Arg249Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000109 in 1,600,444 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00014 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00011 ( 1 hom. )
Consequence
NFKBIL1
NM_005007.4 missense
NM_005007.4 missense
Scores
1
5
12
Clinical Significance
Conservation
PhyloP100: 1.58
Genes affected
NFKBIL1 (HGNC:7800): (NFKB inhibitor like 1) This gene encodes a divergent member of the I-kappa-B family of proteins. Its function has not been determined. The gene lies within the major histocompatibility complex (MHC) class I region on chromosome 6. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04575938).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NFKBIL1 | NM_005007.4 | c.746G>A | p.Arg249Gln | missense_variant | 4/4 | ENST00000376148.9 | |
NFKBIL1 | NM_001144961.2 | c.701G>A | p.Arg234Gln | missense_variant | 4/4 | ||
NFKBIL1 | NM_001144962.2 | c.677G>A | p.Arg226Gln | missense_variant | 4/4 | ||
NFKBIL1 | NM_001144963.2 | c.632G>A | p.Arg211Gln | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NFKBIL1 | ENST00000376148.9 | c.746G>A | p.Arg249Gln | missense_variant | 4/4 | 1 | NM_005007.4 | P4 | |
NFKBIL1 | ENST00000376145.8 | c.701G>A | p.Arg234Gln | missense_variant | 4/4 | 1 | |||
NFKBIL1 | ENST00000376146.8 | c.677G>A | p.Arg226Gln | missense_variant | 4/4 | 4 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152220Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
22
AN:
152220
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000186 AC: 40AN: 215454Hom.: 0 AF XY: 0.000186 AC XY: 22AN XY: 118062
GnomAD3 exomes
AF:
AC:
40
AN:
215454
Hom.:
AF XY:
AC XY:
22
AN XY:
118062
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000106 AC: 153AN: 1448106Hom.: 1 Cov.: 35 AF XY: 0.000103 AC XY: 74AN XY: 719072
GnomAD4 exome
AF:
AC:
153
AN:
1448106
Hom.:
Cov.:
35
AF XY:
AC XY:
74
AN XY:
719072
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000144 AC: 22AN: 152338Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 10AN XY: 74502
GnomAD4 genome
AF:
AC:
22
AN:
152338
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
18
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.746G>A (p.R249Q) alteration is located in exon 4 (coding exon 4) of the NFKBIL1 gene. This alteration results from a G to A substitution at nucleotide position 746, causing the arginine (R) at amino acid position 249 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Benign
T;T;T
Polyphen
D;.;.
Vest4
MVP
MPC
0.71
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at